drugset / Trial / NCT06209359
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Phase 1
Recruiting
50 enrolled
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedCrossoverTriple-blindOther
Summary
Randomized double-blind placebo-controlled crossover study design
Timeline
- Start
- 2024-07-24
- Primary completion
- 2029-03-01
- Completion
- 2029-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ammonium Chloride | Small molecule | 75 mmol | Oral |